Immuneering Corporation (IMRX) Misses Q4 EPS by 13c

Immuneering Corporation (NASDAQ: IMRX) reported Q4 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Tutor Perini wins $60M Coast Guard contract in Florida
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'